National Cheng Kung University
Tainan, Tainan City 70403
1 studies enrolling now · 4 studies all time
What they study most
ALK-positive Advanced NSCLC, Non-Small Cell Lung Cancer, Plaque Psoriasis, Psoriatic Arthritis
Studies at this site
- A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines — Recruiting now
- A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
- A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib — Completed
- Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET — Completed